Delivery Order SPE2DB22D2206-SPE2DB25FGS49
Award Date 4/24/25
Potential Completion Date 4/25/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ontruzant 150 mg vials, with a ceiling value of $10,882.70. This firm fixed-price, non-competitive set-aside delivery order is scheduled for completion by August 5, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. Ontruzant is a biosimilar therapeutic used in oncology treatment, reflecting the...
- The Defense Logistics Agency awarded a $5,748.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials, with an ultimate completion date of August 22, 2025. The contract, issued on August 21, 2025, is a non-set-aside award reflecting open competition. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, serving as the prime contractor with no subcontractors identified. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ontruzant 150 mg vials, a biosimilar to trastuzumab used in cancer treatment. This firm fixed-price delivery order, valued at $6,808.01, represents a non-competitive set-aside contract and carries an ultimate completion date of July 28, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Ontruzant 150 mg vials valued at $10,937.50 on September 23, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by September 24, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside...
- The U.S. Defense Department's Medical Supply Chain awarded a $11,764.70 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Ontruzant 150 mg vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as...
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $6,647.56 to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on August 4, 2025, with a final delivery date of August 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,445.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ontruzant 420 mg vials, with completion scheduled for September 22, 2025. This competitive award, which included no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $28,115.42 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ontruzant 420 mg vials, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ontruzant is a biosimilar to Herceptin used in oncology treatments, reflecting AmerisourceBergen's role...
- The Defense Logistics Agency's Medical Supply Chain awarded a $6,766.79 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Ontruzant 150 mg vials. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract under open competition. The order is set to be completed by June 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,014.60 for 420 mg vials of Ontruzant on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price contract, issued with no set-aside designation, was competitively awarded by the Defense Logistics Agency's Medical Supply Chain to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...